Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Recruiting N/A Interventional Study
Methamphetamine Use Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
200 (estimated)
Sponsor
Oregon Health and Science University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient-defined regular use of methamphetamine in the last year * Any methamphetamine use in the past 30 days * Age 18 years or older * No client-reported diagnosis of heart failure * Able to communicate in English * Screen positive for potential methamphetamine-associated hea…
Contacts

Brian Chan, MD, MPH

503-494-2010

chanbri@ohsu.edu

CONTACT

Kellie Pertl, MPH

pertl@ohsu.edu

CONTACT